Drug Profile
Pregabalin controlled release - Intellipharmaceutics
Alternative Names: Pregabalin extended-release capsules; Pregabalin XR; Pregabalin XR - Intellipharmaceutics; Regabatin XRLatest Information Update: 08 Mar 2023
Price :
$50
*
At a glance
- Originator Intellipharmaceutics International
- Class Aminobutyric acids; Analgesics; Antiepileptic drugs; Anxiolytics; Gabapentinoids; Neuroprotectants; Small molecules
- Mechanism of Action CACNA2D1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I Fibromyalgia; Neuropathic pain
Most Recent Events
- 08 Mar 2023 Phase I clinical trial is still ongoing for Fibromyalgia and Neuropathic pain (In volunteers) in Canada (PO)
- 28 Apr 2021 No recent reports of development identified for phase-I development in Neuropathic-pain(In volunteers) in Canada (PO, Controlled release)
- 29 Mar 2019 Phase-I development for Neuropathic pain is ongoing in Canada